Price Vision Group
10 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Loteprednol Etabonate 0.25% for Prevention of Cornea Transplant Rejection (NCT05136443) | Price Vision Group | 2021-11-23 |
| Corneal Crosslinking for Treatment of Corneal Neovascularization (NCT04787471) | Price Vision Group | 2021-05-03 |
| Effect of Xen Implantation on the Aqueous Humor Proteome (NCT04141865) | Price Vision Group | 2019-10-24 |
| Rhopressa for Corneal Edema Associated With Fuchs Dystrophy (NCT04051463) | Price Vision Group | 2019-08-05 |
| Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration (NCT03971357) | Price Vision Group | 2019-07-22 |
| Comparison of Standard vs. Accelerated Corneal Crosslinking (NCT03922542) | Price Vision Group | 2019-04-16 |
| Effect of TrueTear Corneal Surface Imaging (NCT03637348) | Price Vision Group | 2018-08-13 |
Track Price Vision Group automatically
Every clearance here is in the API, with alerts when new ones post.